Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

Summary

Cystic Fibrosis patients attending with infective exacerbations will be enrolled into the study. The trial is a double blinded, randomised trial with patients randomised to 10,14 or 21 days of antibiotic therapy, comprising of tobramycin and either ceftazidime or meropenem.

Timeline

Start

2010-01

Primary completion

2010-10

Completion

2011-04

Drugs

Indications